For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the introduction of this treatment and Attruby represents a significant breakthrough . These innovative therapies protect the transthyretin protein, slowing its harmful build-up and alleviating the burden of the illness. Individuals are now reporting… Read More